trial · primary record
Sefaxersen (RO7434656)
Primary IgA Nephropathy
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 459 |
| Primary completion | 2029-08-31 |
| Primary endpoint | Change From Baseline in the Urine Protein-to-Creatinine Ratio (UPCR) at Week 37 |
| Registry ID | NCT05797610 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:27.108Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05797610
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.